The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of T H9 cells

Nature Immunology

Volumn 15, Issue 8, 2014, Pages 758-766

  Végran, Frédérique ^a,b   Berger, Hélène ^a,b   Boidot, Romain ^c   Mignot, Grégoire ^a,b   Bruchard, Mélanie ^a,b   Dosset, Magalie ^a,b   Chalmin, Fanny ^a,b   Rébé, Cédric ^a,b,c   Dérangère, Valentin ^a,b   Ryffel, Bernhard ^d,e   Kato, Masashi ^f   Prévost Blondel, Armelle ^g,h   Ghiringhelli, François ^a,b,c   Apetoh, Lionel ^a,b,c  

^a Chu   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

^d University and CNRS   (France)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g INSTITUT COCHIN   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYANIDIN 3 GLUCOSIDE; CYCLOPHOSPHAMIDE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 9; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE FYN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1BETA; SMALL INTERFERING RNA; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; GENE EXPRESSION; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG ADENOCARCINOMA; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA SEQUENCE; TH9 CELL; ADOPTIVE TRANSFER;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL LINE; FEMALE; GREEN FLUORESCENT PROTEINS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-9; INTERLEUKINS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FYN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, RNA; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84904656835     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2925     Document Type: Article

References (50)

1. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. & Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
2. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
3. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663 (2011).
4. Sakaguchi, S., Miyara, M., Costantino, C.M. & Hafler, D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490-500 (2010).
5. Dardalhon, V. et al. IL-4 inhibits TGF-induced Foxp3+ T cells and, together with TGF-, generates IL-9+IL-10+Foxp3- effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
6. Veldhoen, M. et al. Transforming growth factor- 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
7. Jäger, A., Dardalhon, V., Sobel, R.A., Bettelli, E. & Kuchroo, V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177 (2009).
8. Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192-202 (2010).
9. Chang, H.C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527-534 (2010).
10. Rengarajan, J. et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003-1012 (2002).
11. Klemsz, M.J., McKercher, S.R., Celada, A., Van Beveren, C. & Maki, R.A. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61, 113-124 (1990).
12. Purwar, R. et al. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat. Med. 18, 1248-1253 (2012).
13. Lu, Y. et al. Th9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122, 4160-4171 (2012).
14. Ghiringhelli, F. et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1-dependent adaptive immunity against tumors. Nat. Med. 15, 1170-1178 (2009).
15. Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576-587 (2009).
16. Horka, H. et al. The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. J. Immunol. 188, 2669-2676 (2012).
17. Taki, S. et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6, 673-679 (1997).
18. Lohoff, M. et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6, 681-689 (1997).
19. Nizamutdinova, I.T. et al. Anthocyanins from black soybean seed coats preferentially inhibit TNF-alpha-mediated induction of VCAM-1 over ICAM-1 through the regulation of GATAs and IRF-1. J. Agric. Food Chem. 57, 7324-7330 (2009).
20. Kara, E.E. et al. Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites. J. Immunol. 191, 1110-1117 (2013).
21. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150 (1998).
22. Burns, K. et al. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273, 12203-12209 (1998).
23. Shuai, K., Schindler, C., Prezioso, V.R. & Darnell, J.E. Jr . Activation of transcription by IFN-: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258, 1808-1812 (1992).
24. Varinou, L. et al. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity 19, 793-802 (2003).
25. Darnell, J.E. Jr., Kerr, I.M. & Stark, G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994).
26. Liu, A. et al. TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia. J. Biol. Chem. 287, 16132-16145 (2012).
27. Kato, M. et al. Transgenic mouse model for skin malignant melanoma. Oncogene 17, 1885-1888 (1998).
28. Lengagne, R. et al. Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells. Cancer Res. 64, 1496-1501 (2004).
29. Eyles, J. et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest. 120, 2030-2039 (2010).
30. Frederiksen, K.S. et al. IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma. Cancer Immunol. Immunother. 57, 1439-1449 (2008).
31. Spolski, R. & Leonard, W.J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26, 57-79 (2008).
32. Schmitt, E. et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF- and IL-4, and is inhibited by IFN. J. Immunol. 153, 3989-3996 (1994).
33. Miyamoto, M. et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN- gene regulatory elements. Cell 54, 903-913 (1988).
34. Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655 (2001).
35. Honda, K. & Taniguchi, T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644-658 (2006).
36. Elser, B. et al. IFN- represses IL-4 expression via IRF-1 and IRF-2. Immunity 17, 703-712 (2002).
37. Kano, S. et al. The contribution of transcription factor IRF1 to the interferon-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat. Immunol. 9, 34-41 (2008).
38. Jäger, A. & Kuchroo, V.K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 72, 173-184 (2010).
39. Muranski, P. et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35, 972-985 (2011).
40. Okamoto, M. et al. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J. Biol. Chem. 285, 6477-6488 (2010).
41. Zeng, R. et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201, 139-148 (2005).
42. Petrella, T.M. et al. Interleukin-21 has activity in patients with metastatic melanoma: a Phase II study. J. Clin. Oncol. 30, 3396-3401 (2012).
43. Dudley, M.E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850-854 (2002).
44. Muranski, P. & Restifo, N.P. Adoptive immunotherapy of cancer using CD4+ T cells. Curr. Opin. Immunol. 21, 200-208 (2009).
45. Hunder, N.N. et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N. Engl. J. Med. 358, 2698-2703 (2008).
46. Steenwinckel, V. et al. IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J. Immunol. 178, 3244-3251 (2007).
47. Taylor, J., Schenck, I., Blankenberg, D. & Nekrutenko, A. in Current Protocols in Bioinformatics (ed. Minor, W.) Ch. 10, Unit 10 15 (Wiley Online Library, 2007).
48. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
49. Trapnell, C., Pachter, L. & Salzberg, S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
50. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).